Dr. Janet Woodcock Delivers Keynote at Biomarker Qualification Workshop
2018 Annual Meeting - Afternoon Keynote with Dr. Janet WoodcockПодробнее
Janet WoodcockПодробнее
Partnering for Innovation: FDA's Janet WoodcockПодробнее
About FDA’s Biomarker Qualification ProgramПодробнее
Making Biomarker Development SuccessfulПодробнее
2021 REdI Conference Keynote Address by Janet Woodcock, MDПодробнее
Janet Woodcock, FDA, on future innovation in drug developmentПодробнее
Dr. Janet WoodcockПодробнее
What Are Biomarkers And Why Are They Important?Подробнее
Dr. Woodcock's Keynote to FDLI Annual Conference - 5/18/2021Подробнее
FDA Official Janet Woodcock Discusses Ideas to Improve Drug DevelopmentПодробнее
Exclusive Interview with Dr. Janet Woodcock，Former Principal Commissioner of FDA at the SAPA 2024 ACПодробнее
FDA's Janet Woodcock's Presentation at 2014 RAPS: The Regulatory ConvergenceПодробнее
7/24/2019 - Session 2: Janet WoodcockПодробнее
FDA's Janet Woodcock Speaks to Arthritis Foundation Osteoarthritis Workshop AttendeesПодробнее
Biomarkers vs Traditional Outcome Measures - What the FDA ThinksПодробнее
